Description: TEMPE, Ariz., January 13, 2026--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new initiative with the Canadian Foundation for the Advancement of Orthodontics (CFAO). Under this initiative, Align has committed to support Invisalign treatment for 30 eligible pati

Description: Event context and recent share performance Align Technology (ALGN) has been drawing investor attention after a period of mixed share performance, with the stock showing a monthly gain alongside a weaker past year and multiyear track record. See our latest analysis for Align Technology. Align Technology’s recent 7 day share price return of 6.83% and 90 day share price return of 26.50% contrast with a 1 year total shareholder return decline of 22.55%. This suggests short term momentum against a...

Description: Align Technology is scheduled to report its fourth-quarter results next month, and analysts expect a double-digit earnings increase.

Description: Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the fund’s Investor Class fund ARTQX returned 0.97%, Advisor Class fund APDQX posted a return of 0.98%, and Institutional Class fund APHQX returned 0.97%, compared to […]

Description: TEMPE, Ariz., January 02, 2026--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (2:0

Description: Deckers Brands and Align Technology headline two S&P 500 stocks down 50%-80% from highs, with solid balance sheets and growth outlooks heading into 2026.

Description: Investors might want to be greedy while others are fearful and buy two hard-hit S&P 500 stocks that are trading 50% and 80% below their highs right now.

Description: Align Technology (ALGN) is back in the spotlight after Jim Cramer suggested investors "take a pass" and Meridian Growth Fund disclosed it trimmed its stake, citing weaker teen conversion rates and intensifying competitive pressure. See our latest analysis for Align Technology. The share price has bounced to $157.84 with a robust 90 day share price return of 26.39 percent and a 30 day share price return of 9.89 percent, but that short term momentum contrasts with a weaker 1 year total...

Description: Align Technology (NASDAQ:ALGN) has had a great run on the share market with its stock up by a significant 26% over the...

Description: Align Technology, Inc. (NASDAQ:ALGN) is one of the stocks Jim Cramer answered questions about. A caller was bullish on the company but mentioned their worry that the competition in the industry is increasing. Cramer replied: “Yeah, well, that’s the problem. I loved this company when it was the only game in town, but the fact […]

Description: The global dental 3D printing market is set to surge, projected to reach USD 10.06 billion by 2030 from USD 3.96 billion in 2025, boasting a CAGR of 20.5%. Key growth drivers include rising oral health awareness, technological advancements in 3D printing, and an aging population needing dental restorations. VAT photopolymerization leads the technology market due to its precision and efficiency. The resins segment will experience the highest growth in dental 3D printing materials, fueled by innov

Description: Align Technology has underperformed the S&P 500 over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Description: If you have ever wondered whether Align Technology is a bargain or a value trap at its current price, this breakdown is for you. The stock has bounced about 2.6% over the last week and 15.0% over the past month, but it is still down sharply, with a 23.7% decline year to date and a 33.6% decline over the past year, highlighting both potential upside and lingering skepticism. Recent headlines have focused on Align's ongoing innovation in clear aligners, its expanding digital orthodontics...

Description: Pre-Market Stock Futures: The futures are trading flat on Tuesday after we opened the week on the downside, with all major indices finishing the day lower. With the Federal Reserve meeting this week, investors are playing a wait-and-see game before bidding stocks higher to ensure there will indeed be a 25-basis-point cut. Wall Street will ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Agilent, Alibaba, Delta Air Lines, Intel, JD.com, Micron Technology, Reddit and More

Description: Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.

Description: BANGKOK, December 09, 2025--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in Thailand of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and dental correction b

Description: TEMPE, Ariz., December 03, 2025--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today shared highlights from its participation at the Greater New York Dental Meeting (GNYDM) 2025, one of the largest annual dental congresses in the United States.

Description: Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities hit a record high in the third quarter, fueled by continued gains in technology and falling bond yields. Easing tariff rhetoric and renewed AI infrastructure investments boosted large tech stocks. […]

Description: Align Technology (ALGN) got investor attention after announcing the launch of its Invisalign System with mandibular advancement in the Philippines. This move brings a new solution for correcting Class II dental issues to a growing international market. See our latest analysis for Align Technology. The latest product launch has given Align Technology a boost, with the share price up over 6% in the last month as investors responded to signs of innovation and international growth. Still, broader...

Description: Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: Check out the companies making headlines this week:

Description: Check out the companies making headlines yesterday:

Description: TEMPE, Ariz. & SAN JOSE, Calif., November 26, 2025--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced top-tier recognition in the 2025 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates

Description: Align Technology's stock narrative has shifted as analysts recently reaffirmed their fair value estimate at $180.50 per share. This indicates stable long-term expectations despite evolving market sentiment. While the discount rate has improved slightly to reflect a more favorable risk environment and revenue growth projections have inched upward, overall analyst perspectives remain mixed. Stay tuned to discover how investors and observers can keep pace with these ongoing shifts in outlook and...

Description: Shares of dental technology company Align Technology (NASDAQ:ALGN) jumped 6.2% in the afternoon session after the company announced the commercial availability of its Invisalign System with mandibular advancement in the Philippines.

Description: Align Technology recently announced the commercial launch in the Philippines of its Invisalign System with mandibular advancement, a clear aligner featuring integrated solid occlusal blocks to address Class II skeletal and dental correction. This marks the company's first clear aligner designed for simultaneous dental alignment and mandibular advancement, aimed at providing more predictable treatment outcomes for complex orthodontic cases. We'll examine how the launch of this...

Description: MANILA, Philippines, November 25, 2025--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in the Philippines of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and

Description: Despite Align Technology's weak performance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Description: A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to

Description: The United States Orthodontics Market, valued at USD 2.04 billion in 2024, is projected to surge to USD 5.02 billion by 2033, driven by a CAGR of 10.5%. This growth is fuelled by increasing awareness of dental aesthetics, advancements in clear aligners, and a rising demand for early orthodontic treatments among children and adolescents. The U.S. orthodontics market is segmented by products (instruments, supplies), age groups (adult, teen), and end users (hospitals, dental clinics). Key players i

Description: The market for Align Technology, Inc.'s ( NASDAQ:ALGN ) shares didn't move much after it posted weak earnings recently...

Description: A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.

Description: Align Technology (ALGN) delivered quarterly results that surpassed expectations, fueled by strong international demand and a surge in teen and kids segments. Management also pointed to record global doctor participation and multiple product innovations that are driving momentum. See our latest analysis for Align Technology. Despite ongoing product launches and buyback activity, Align Technology’s share price has yet to recover from its larger declines earlier in the year. The stock has...

Description: A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

Description: Align Technology delivered third-quarter results that exceeded Wall Street’s expectations, with international demand for its Clear Aligner products and traction among teens and kids segments playing central roles. Management cited double-digit Clear Aligner volume growth in EMEA and APAC regions, and strong adoption of innovations like the Invisalign Palatal Expander, as key performance drivers. CEO Joe Hogan highlighted that “88,000 doctors globally submitted Invisalign cases, an all-time recor

Description: TEMPE, Ariz., November 04, 2025--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Te

Description: TEMPE, Ariz., November 03, 2025--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2026 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to

Description: Seasoned finance executive brings public company, capital markets and transaction experience to support next phase of growthSARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the appointment of David Garcia as Senior Vice President of Finance, effective November 3, 2025. Mr. Garcia brings more than 20 years of financial leadership

Description: Align Technology (ALGN) saw earnings decline by 28.3% per year over the past five years, with its net profit margin dropping to 9.5% from 11.1% the year before. Despite this, the company is expected to turn a corner, as projections call for EPS growth of 18.1% per year and revenue growth of 4.8% per year. However, that revenue pace trails the US market’s 10.3% average. The latest results show tighter margins, but upbeat forecasts and a strong history of quality earnings could help underpin...

Description: Shares of dental technology company Align Technology (NASDAQ:ALGN) jumped 6.1% in the morning session after the company reported strong third-quarter results that beat revenue and earnings forecasts, driven by higher demand for its Invisalign clear aligners. Revenue for the quarter reached $995.7 million, up 1.8% from the previous year, while adjusted earnings came in at $2.61 per share, both surpassing Wall Street's expectations. The positive results were supported by a 4.9% year-on-year increa

Description: Align stock had a good, not great, quarter -- and still costs too much.

Description: Align Technology jumps 15% after Q3 earnings and revenues beat estimates, though steep margin declines weigh on results.

Description: Align Technology stock jumped Thursday as the Invisalign parent’s third-quarter earnings tempered concerns about falling demand for its clear aligners. Adjusted earnings for the third quarter came in at $2.61 a share, surpassing the $2.40 consensus among analysts polled by FactSet. Total revenue was $995.7 million, up 1.8% from the same period last year but down 1.7% from the previous quarter.

Description: Dental technology company Align Technology (NASDAQ:ALGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 1.8% year on year to $995.7 million. The company expects next quarter’s revenue to be around $1.04 billion, close to analysts’ estimates. Its non-GAAP profit of $2.61 per share was 8.4% above analysts’ consensus estimates.

Description: Dental technology company Align Technology (NASDAQ:ALGN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 1.8% year on year to $995.7 million. The company expects next quarter’s revenue to be around $1.04 billion, close to analysts’ estimates. Its non-GAAP profit of $2.61 per share was 8.4% above analysts’ consensus estimates.

Description: The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: Align Technology (ALGN) delivered earnings and revenue surprises of +10.13% and +2.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $2.37 per share. The maker of the Invisalign tooth-straightening system posted revenue of $995.7 million in the period, also surpassing Street forecasts.

Description: TEMPE, Ariz., October 29, 2025--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'25"). Q3'25 total revenues were $995.7 million, down 1.7% sequentially and up 1.8% year-over-year. Q3'25 total revenues were favorably impact

Description: SAN JOSE, Calif. & TEMPE, Ariz. & PETACH TIKVA, Israel, October 29, 2025--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced a series of new product innovations for iTero™ Digital Solutions, a comprehensive ecosystem that includes intraoral scanners and integrated software tools that are designed to transform dental c

Description: SAN JOSE, Calif. & TEMPE, Ariz., October 29, 2025--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced ClinCheck® Live Plan, a new feature in its Invisalign® digital treatment planning that automates the generation of initial doctor-ready treatment plans within 15 minutes. This advancement represents a major technologi

Description: Shares of Align Technology (ALGN) are up 0.30% today, but the real action is happening off the tape. Reddit mentions on r/wallstreetbets surged dramatically over the past 48 hours, with sentiment shifting from neutral to outright bullish as retail investors spot what they see as a buying opportunity. The stock has pulled back 2.2% from ... Retail Traders Change Tune on Align Stock (ALGN) After Steep Pullback

Description: Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Align Technology (ALGN) shares have mostly traded sideways recently, attracting the attention of investors who are monitoring the company's ongoing performance. With recent returns still lagging behind prior highs, valuation remains an area of interest in this situation. See our latest analysis for Align Technology. This year has seen Align Technology’s share price endure significant pressure, with momentum continuing to fade as the 1-year total shareholder return has slumped to -40.6%. Even...

Description: Align Technology, Inc. (NASDAQ:ALGN) is one of the stocks Jim Cramer recently offered insights on. When a caller asked about the company during the latest Mad Money episode, Cramer said: “I want you to go. I know it’s a low price-to-earnings multiple, but I just think there are a lot of forces against it. Let’s […]

Description: Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 13.6% gain for healthcare stocks has fallen short of the S&P 500’s 25.5% rise.